Shanghai, China

Mengying Wang

This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Hyamab Biotech Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mengying Wang. Retrieved from https://idiyas.com/inventor/mengying-wang-jsx8dekl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mengying Wang: Innovator in Antibody Development

Introduction

Mengying Wang is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work is crucial for advancements in medical treatments and therapies.

Latest Patents

Mengying Wang holds a patent for the invention titled "NKG2A Antibody, Preparation Method Therefor and Application Thereof." This patent represents her innovative approach to antibody development, which has potential applications in various therapeutic areas. She has 1 patent to her name, showcasing her expertise and dedication to her field.

Career Highlights

Mengying Wang is currently employed at Shanghai Hyamab Biotech Co., Ltd. This company is known for its focus on developing innovative biopharmaceuticals. Her role at the company allows her to work on cutting-edge research and contribute to the advancement of biotechnology.

Collaborations

Throughout her career, Mengying Wang has collaborated with notable colleagues, including Qing Duan and Lile Liu. These collaborations have enhanced her research and contributed to the success of her projects.

Conclusion

Mengying Wang is a talented inventor whose work in antibody development is paving the way for future medical innovations. Her contributions to biotechnology are invaluable, and her ongoing research promises to lead to significant advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…